Aprea Therapeutics ($APRE) Insider Trading & Smart Money Activity
Aprea Therapeutics, Inc. ($APRE) has 16 insider trades on file. Insiders filed 16 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
APRE insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All APRE insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Bernd Seizinger | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Bernd Seizinger | Buy (Grant or award) | 3.13K sh | +13.7% | -5.5% | — | |||||
| Insider | Richard Peters | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | Read | |||||
| Insider | Richard Peters | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Rifat Pamukcu | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Rifat Pamukcu | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Henneman John III | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | Read | |||||
| Insider | Henneman John III | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Gabriela Gruia | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | Read | |||||
| Insider | Gabriela Gruia | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Michael Grissinger | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Michael Grissinger | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Marc Duey | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Marc Duey | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Jean-Pierre Bizzari | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — | |||||
| Insider | Jean-Pierre Bizzari | Buy (Grant or award) | 12.55K sh | +13.7% | -5.5% | — |
1W / 1M / 6M = how APRE moved from the trade or filing date.
Insider trading in APRE: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Bernd Seizinger | 2 | — | Jun 16, 2026 | ||
| Richard Peters | 2 | — | Jun 16, 2026 | ||
| Rifat Pamukcu | 2 | — | Jun 16, 2026 | ||
| Henneman John III | 2 | — | Jun 16, 2026 | ||
| Gabriela Gruia | 2 | — | Jun 16, 2026 | ||
| Michael Grissinger | 2 | — | Jun 16, 2026 | ||
| Marc Duey | 2 | — | Jun 16, 2026 | ||
| Jean-Pierre Bizzari | 2 | — | Jun 16, 2026 |
Frequently asked questions
What is the latest insider trade in APRE?
Bernd Seizinger filed a buy (grant or award) of 12.55K sh on Jun 16, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.